Furans
![eMolecules 7-Bromobenzo[d]oxazol-2(3H)-one | 871367-14-5 | MFCD11111731 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502137456.JPG-250.jpg)
eMolecules 7-Bromobenzo[d]oxazol-2(3H)-one | 871367-14-5 | MFCD11111731 | 1g
Ambeed | 7-Bromobenzo[d]oxazol-2(3H)-one | 1g | 600831202 | A150964 | | 871367-14-5 | MFCD11111731 | 214.018 | C7H4BrNO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Furazolidone | 500 MG
Furazolidone is a monoamine oxidase (MAO) inhibitor with antiproliferative, apoptosis-inducing and differentiation-promoting activities. It may inhibit leukemia fusion protein-mediated bone marrow transformation by upregulating the stability of the tumor suppressor protein p53, and exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Inhibits monoamine oxidase (MAO).
- Demonstrates antiproliferative activity.
- Induces apoptosis.
- Promotes differentiation.
- May inhibit leukemia fusion protein-mediated bone marrow transformation.
- Upregulates stability of tumor suppressor protein p53.
- Exhibits anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Suitable for anti-AML research.
Medchemexpress LLC Furazolidone | 67-45-8 | MFCD00010550 | 1 ML
Furazolidone is a monoamine oxidase (MAO) inhibitor that possesses antiproliferative, apoptosis-inducing, and differentiation-promoting characteristics. It has the potential to inhibit leukemia fusion protein-mediated bone marrow transformation by increasing the stability of the tumor suppressor protein p53. Furthermore, Furazolidone demonstrates anti-leukemic activity in acute myeloid leukemia (AML) cell lines and is suitable for anti-AML research.
- Monoamine oxidase (MAO) inhibitor.
- Exhibits antiproliferative activity.
- Induces apoptosis.
- Promotes differentiation.
- May inhibit leukemia fusion protein-mediated bone marrow transformation.
- Upregulates the stability of tumor suppressor protein p53.
- Shows anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Can be used for anti-AML research.
Medchemexpress LLC HY-18600A 5mg Medchemexpress, Azimilide (Dihydrochloride) CAS:149888-94-8 Purity:>98%
Medchemexpress, HY-18600A 5mg Azimilide (Dihydrochloride) CAS:149888-94-8 Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Methyl protogracillin | 54522-53-1 | MFCD32197353 | 99.0% | 1079.23 | C52H86O23 | 10 MG
Methyl protogracillin is a steroidal saponin natural product isolated from the roots of Dioscorea opposite Thunb. It has reported anticancer activity and is supplied for laboratory research use as a solid with high purity.
- Steroidal saponin natural product isolated from plant roots.
- Reported anticancer activity in the literature.
- High purity suitable for research (99.03%).
- Supplied as a solid in a 10 mg pack size.
- Molecular weight 1,079.23; formula C52H86O23.
- Store at -20°C and protect from light; follow laboratory safety procedures.
Medchemexpress LLC Mometasone furoate-13C,d6 | 83919-23-7 | 99.7% | 528.46 | 1 MG
Mometasone furoate-13C,d6 is a glucocorticoid receptor agonist with both anti-inflammatory and anti-allergic properties, acting as a corticosteroid agent. It is utilized for topical applications in chronic skin eczema and for managing airway inflammation in asthma. The compound functions by binding to glucocorticoid receptors, inducing conformational changes, and facilitating nuclear translocation.
- Glucocorticoid receptor agonist.
- Possesses anti-inflammatory and anti-allergic activity.
- Acts as a corticosteroid agent.
- Used for topical applications in chronic skin eczema.
- Used in management of airway inflammation in asthma in vivo.
- Inhibits LPS-stimulated nitrite production in J774 macrophages.
- More potent than Dexamethasone in inhibiting iNOS expression.
- Significantly inhibits cox-2 protein expression.
Medchemexpress LLC Azimilide | 149908-53-2 | MFCD00867099 | 99.0% | 457.95 | C23H28ClN5O3 | 10 MG
Azimilide is a class III antiarrhythmic agent used in research to block cardiac delayed rectifier potassium channels (IKs and IKr). It is commonly used in electrophysiology and arrhythmia studies to probe ion channel function and pharmacological effects.
- Class III potassium channel blocker targeting IKs and IKr.
- Also inhibits L-type calcium and sodium currents at higher concentrations.
- Suitable for in vitro electrophysiology and arrhythmia models.
- High purity grade for research use.
- Free base and dihydrochloride salt forms available; follow SDS storage guidance.
Medchemexpress LLC Bliretrigine | 1233229-75-8 | 99.4% | C20H24N4O2 | 50 MG
Bliretrigine is a sodium channel blocker that has the effect of relieving pain.
- Sodium channel blocker
- Relieves pain
- White to off-white solid appearance
- Stable under recommended storage conditions
Medchemexpress LLC Inx-sm-56 | 2734878-18-1 | 99.5% | 576.70 | C32H36N2O6S | 1 MG
INX-SM-56 is a cytotoxin used as an antibody-drug conjugate (ADC) payload for the synthesis of anti-VISTA antibody conjugates. It is supplied as a white-to-yellow solid with high analytical purity and is intended for research use.
- Cytotoxin for antibody-drug conjugate synthesis.
- High purity: 99.47% (analytical).
- Molecular weight: 576.70; formula: C32H36N2O6S.
- CAS number: 2734878-18-1.
- Available in small research sizes such as 1 mg and 5 mg.
- Storage: 4°C, sealed, away from moisture and light; in solvent: -80°C (6 months), -20°C (1 month).
Medchemexpress LLC LY-3381916 (IDO1-IN-5) | 2166616-75-5 | 99.9% | 396.45 | 1 ML
LY-3381916 (IDO1-IN-5) is a potent, selective, and brain-penetrated inhibitor of IDO1 activity. It binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1. This product is for research use only and not sold to patients.
- Potent, selective, and brain-penetrated inhibitor of IDO1 activity.
- Binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1.
- No obvious agonism of aryl hydrocarbon receptor (AHR) up to 100 μM.